A. Brzezinski

J. Achkar, C. Delaney, V. Fazio, 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Comprehensive Evaluation of Inflammatory and Noninflammatory Sequelae of Ileal Pouch-Anal Anastomoses

J. Achkar, C. Delaney, V. Fazio, 2005, The American Journal of Gastroenterology.

Combined Ciprofloxacin and Tinidazole Therapy in the Treatment of Chronic Refractory Pouchitis

V. Fazio, F. Remzi, I. Oikonomou, 2007, Diseases of the colon and rectum.

B. Shen, B. Lashner, A. Atreja, 2013, Digestive Diseases and Sciences.

Treatment of Rectal Cuff Inflammation (Cuffitis) in Patients with Ulcerative Colitis Following Restorative Proctocolectomy and Ileal Pouch-Anal Anastomosis

J. Achkar, V. Fazio, F. Remzi, 2004, American Journal of Gastroenterology.

Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis

J. Achkar, V. Fazio, F. Remzi, 2002, American Journal of Gastroenterology.

A Specific Breath Metabolome Signature Identifies Patients With Inflammatory Bowel Diseases: 1842

R. Dweik, M. Baker, C. Fiocchi, 2015 .

Type of Fistula Determines Response to Infliximab in Patients with Fistulous Crohn's Disease

J. Connor, J. Achkar, B. Lashner, 2004, American Journal of Gastroenterology.

Azathioprine therapy in chronic ulcerative colitis.

E. Prokipchuk, J. Baker, A. Steinhart, 1990, Journal of clinical gastroenterology.

Association Between Immune-Associated Disorders and Adverse Outcomes of Ileal Pouch-Anal Anastomosis

V. Fazio, F. Remzi, I. Lavery, 2009, The American Journal of Gastroenterology.

Maintenance therapy with a probiotic in antibiotic‐dependent pouchitis: experience in clinical practice

J. Achkar, V. Fazio, F. Remzi, 2005, Alimentary pharmacology & therapeutics.

Endoscopic Balloon Dilation of Ileal Pouch Strictures

J. Achkar, C. Delaney, V. Fazio, 2004, The American Journal of Gastroenterology.

Mesalamine for prophylaxis of small bowel Crohn’s disease recurrence

B. Lashner, W. Bauer, A. Brzezinski, 1999, Current gastroenterology reports.

Safety and efficacy of endoscopic dilation for primary and anastomotic Crohn's disease strictures.

F. Rieder, J. Vargo, R. Lopez, 2014, Journal of Crohn's & colitis.

Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases

J. Achkar, A. Garber, B. Shen, 2016, Digestive Diseases and Sciences.

Effect of Withdrawal of Nonsteroidal Anti-Inflammatory Drug Use on Ileal Pouch Disorders

V. Fazio, F. Remzi, I. Lavery, 2007, Digestive Diseases and Sciences.

Severe Adverse Outcomes of Endoscopic Perforations in Patients with and Without IBD

S. Mukewar, R. Lopez, B. Shen, 2014, Inflammatory bowel diseases.

Use of old and new oral 5-aminosalicylic acid formulations in inflammatory bowel disease.

D. Seidner, B. Lashner, A. Brzezinski, 1995, Cleveland Clinic journal of medicine.

An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial.

J. Goldblum, D. Seidner, C. Fiocchi, 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Infliximab is more efficacious for treatment of enterocutaneous fistulas compared to rectovaginal fistulas in patients with Crohn's disease

J. Achkar, B. Lashner, M. Parsi, 2001 .

Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas.

J. Baker, A. Steinhart, A. Brzezinski, 1994, The American journal of gastroenterology.

Use of Infliximab within 3 Months of Ileocolonic Resection is Associated with Adverse Postoperative Outcomes in Crohn’s Patients

J. Church, V. Fazio, F. Remzi, 2008, Journal of Gastrointestinal Surgery.

Treatment of left‐sided ulcerative colitis with butyrate enemas: a controlled trial

J. Baker, A. Steinhart, T. Hiruki, 1996, Alimentary pharmacology & therapeutics.

Amino Acid Position 11 of HLA-DRβ1 is a Major Determinant of Chromosome 6p Association with Ulcerative Colitis

K. Roeder, L. Klei, B. Devlin, 2011, Genes and Immunity.

The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis

K. Shetty, L. Rybicki, B. Lashner, 1999, American Journal of Gastroenterology.

Differentiating risk factors for acute and chronic pouchitis.

M. Al-Haddad, J. Achkar, V. Fazio, 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Defining Complex Contributions of NOD2/CARD15 Gene Mutations, Age at Onset, and Tobacco Use On Crohn's Disease Phenotypes

Judy H. Cho, T. Beaty, R. Duerr, 2003, Inflammatory bowel diseases.

Modified Pouchitis disease activity index: A simplified approach to the diagnosis of pouchitis

J. Connor, J. Achkar, V. Fazio, 2003 .

Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis.

J. Achkar, V. Fazio, F. Remzi, 2001, Gastroenterology.

Indicators of Clinical Response to Treatment with Six-Mercaptopurine or Azathioprine in Patients with Inflammatory Bowel Disease

J. Achkar, D. Seidner, T. Stevens, 2004, Inflammatory bowel diseases.

Predictors of response to infliximab in patients with Crohn's disease.

J. Achkar, J. Hammel, B. Lashner, 2002, Gastroenterology.

Azathioprine formulation optimizes metabolite profile in inflammatory bowel disease

J. Achkar, T. Stevens, B. Lashner, 2004, Alimentary Pharmacology and Therapeutics.

Clinical epidemiology of inflammatory bowel disease

Aaron Brzezinski, B. Lashner, Bret A. Lashner, 1994 .

A Randomized Clinical Trial of Ciprofloxacin and Metronidazole to Treat Acute Pouchitis

J. Achkar, V. Fazio, F. Remzi, 2001, Inflammatory bowel diseases.

Application of Wireless Capsule Endoscopy for the Evaluation of Iron Deficiency Anemia in Patients With Ileal Pouches

V. Fazio, F. Remzi, B. Shen, 2008, Journal of clinical gastroenterology.

Risk factors for pouch failure in patients with different phenotypes of Crohn's disease of the pouch

F. Remzi, I. Lavery, R. Lopez, 2008, Inflammatory bowel diseases.

Risk Factors for Clinical Phenotypes of Crohn's Disease of the Ileal Pouch

V. Fazio, F. Remzi, I. Oikonomou, 2006, The American Journal of Gastroenterology.

A Cost-Effectiveness Analysis of Diagnostic Strategies for Symptomatic Patients with Ileal Pouch-Anal Anastomosis

J. Achkar, V. Fazio, F. Remzi, 2003 .

A cost-effectiveness analysis of diagnostic strategies for symptomatic patients with ileal pouch–anal anastomosis

J. Achkar, V. Fazio, F. Remzi, 2003, American Journal of Gastroenterology.

Modified Pouchitis Disease Activity Index

J. Connor, J. Achkar, V. Fazio, 2003, Diseases of the colon and rectum.

Manometric Evaluation of Evacuatory Difficulty (Dyschezia) in Ileal Pouch Patients

R. Khanna, B. Shen, B. Lashner, 2013, Inflammatory bowel diseases.

Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis.

J. Achkar, V. Fazio, F. Remzi, 2002 .

The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis.

D. Seidner, B. Lashner, A. Brzezinski, 1997, Gastroenterology.

Progress in treatment for Crohn's disease.

A. Brzezinski, 2001 .

Progress in treatment for Crohn's disease

A. Brzezinski, 2001, American Journal of Gastroenterology.

Medical Treatment of Crohn's Disease

B. Lashner, A. Brzezinski, 2001 .

Can patients reliably report quality indicators and disease phenotype? Results from the CrohnsPROMISE trial.: P-2.

J. Achkar, B. Shen, B. Lashner, 2011 .

6-Thioguanine levels versus white blood cell counts in guiding 6-mercaptopurine and azathioprine therapy

J. Achkar, D. Seidner, T. Stevens, 2000, American Journal of Gastroenterology.

Type of fistula determines-response to infliximab in patients with fistulous Crohn's disease

J. Connor, J. Achkar, B. Lashner, 2003 .

Immune-mediated neutropenia and thrombocytopenia in a patient with ulcerative colitis: An unusual hematological association with IBD

J. Brandwein, Young-In Kim, J. Baker, 1995 .

A ‘menopause score’ for postmenopausal hormone replacement therapy

A. Brzezinski, 1994, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Alcohol sclerosis for polycystic liver disease and obstructive jaundice: use of a nasobiliary catheter.

S. Shay, D. Conwell, R. A. Meyer, 1994, The American journal of gastroenterology.

Cancer mortality rates in ulcerative colitis surveillance programs.

B. Lashner, B A Lashner, A Brzezinski, 1994, Gastroenterology.

Worsening risk for the development of dysplasia or cancer in patients with chronic ulcerative colitis.

B. Lashner, B A Lashner, A Brzezinski, 1995, The American journal of gastroenterology.

Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open‐label pilot study

D. Wolf, J. Mordenti, W. Tremaine, 2002, Alimentary pharmacology & therapeutics.

Medical Treatment of Crohn's Disease

A. Brzezinski, 2001 .